10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies

GeoMx Decision is Third Ruling Against NanoString, Showing Serial Infringement of 10x Patents 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell an...

November 20, 2023 | Monday | News
Serina Therapeutics Announces POZ Polymer Technology License Agreement with Pfizer

Serina Therapeutics, Inc. (Serina), a privately held, clinical stage biotechnology company focused on developing its proprietary POZ Platform TMdrug delive...

November 20, 2023 | Monday | News
Cytiva Introduces Groundbreaking Affinity Technology for Versatile Protein Purification

Cytiva, a global leader in life sciences, introduces the innovative Cytiva Protein Select technology, designed to streamline and accelerate recombinant pro...

November 17, 2023 | Friday | News
Legend Biotech Secures Exclusive Global License for CAR-T Therapies Targeting DLL3.

The deal with Novartis seeks to advance Legend Biotech’s autologous CAR-T cell therapy candidate, LB2102, and other potential CAR-T cell therapies ...

November 14, 2023 | Tuesday | News
Hepion Pharmaceuticals Reports Significant Liver Stiffness Reduction in Advanced MASH Liver Disease Study

Demonstrated improvements among best reported of fibrosis-reducing compounds - - Liver stiffness results complemented by positive changes in disease bioma...

November 14, 2023 | Tuesday | News
Novo Nordisk Executive Vice President, Henrik Wulff, Affirms Commitment with Significant Investment in New API Facility for Global Capacity Expansion

Novo Nordisk  announced plans to invest more than 42 billion Danish kroner starting in 20231 to expand existing manufacturing facilities in Kalundborg...

November 13, 2023 | Monday | News
Researchers Assemble Nine Synthetic Yeast Chromosomes

The assembly of the chromosomes, and a set of related biological insights, are among the findings published online November 8 in 10 papers in the journals ...

November 09, 2023 | Thursday | News
Parse Biosciences Extends Global Reach with India-based Spinco Biotech Partnership

“We’re seeing increased demand for Parse’s Evercode single cell sequencing solutions across Asia, and we believe our products are poised ...

November 08, 2023 | Wednesday | News
Gilead's CEO, Daniel O'Day, Steers the Ship to Two Years of Unwavering Growth in Virology and Oncology

Product Sales Excluding Veklury Increased 5% Year-Over-Year to $6.4 billion Biktarvy Sales Increased 12% Year-Over-Year to $3.1 billion Oncology Sales In...

November 08, 2023 | Wednesday | Company results
Cellares and Cabaletta Bio Join Forces for Automated Manufacturing of CABA-201 on Cell Shuttle Platform

-Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, an...

November 07, 2023 | Tuesday | News
Senti Bio Collaborates with Celest Therapeutics to Advance SENTI-301A in China

– Celest to lead clinical development with technical support from Senti Bio – – First patient expected to be enrolled in China in 1H 202...

November 07, 2023 | Tuesday | News
QIAGEN launches complete Sample to Insight workflow for microbiome research

QIAGEN announced the launch of the Microbiome WGS SeqSets, a comprehensive Sample to Insight workflow designed to provide an easy-to-use solution that maxi...

November 07, 2023 | Tuesday | News
Africa CDC Director General Visits SK bioscience to Discuss Vaccine Localization in Africa

H.E Dr. Jean Kaseya, Director General of the African Centers for Disease Control and Prevention (Africa CDC), visited SK bioscience t...

November 06, 2023 | Monday | News
Boehringer Ingelheim Hits Milestone in CKD: Promising Phase II Results with Aldosterone Synthase Inhibitor + Empagliflozin

Phase II results demonstrated significant albuminuria reductions by up to 39.5% vs. placebo when BI 690517, a novel selective aldosterone synthase inhibi...

November 06, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in